Navigation Links
Chicago-Area Infertility Specialist Richard Sherbahn Presents New Research Showing that High AMH levels are Correlated with Better IVF Outcomes
Date:10/25/2013

Gurnee, IL (PRWEB) October 25, 2013

Infertility specialist Richard Sherbahn, MD, recently presented research on how the female partner’s AMH blood levels relates to in vitro fertilization outcome at the annual meeting of the American Society for Reproductive Medicine in Boston, Massachusetts. The study points to the possibility that aggressive ovarian stimulation and augmentation protocols Dr. Sherbahn uses at the Advanced Fertility Center of Chicago bolster the success rates in women under 35.

Dr. Sherbahn studied 786 IVF cycles in women under 35 years old who had ovarian stimulation for IVF. The patients were separated into three groups according to their AMH level. The low group had an AMH of less than 0.6 ng/ml, the middle group had levels between 0.6 and 1.5 and the high group had levels greater than 1.5.

The study compared the percentage of cycle cancellations, the average number of eggs retrieved, and the live birth rate per cycle for the three AMH groups.

Dr. Sherbahn found much higher rates of cycle cancellation in the low AMH group as compared to that seen in the middle group and the high group. The low AMH group had a cancellation rate of 15.1% compared to 3.7% in the middle group and 0.4% in the high group.

The average number of eggs retrieved in the low group was 7.0, in the middle group it was 9.3, and in the high group 14.2.

The surprising finding of this study was that the live birth rate per cycle was not different between the low AMH group and the middle AMH group. The low AMH group had a live birth rate of 43.4% and the middle AMH group had a live birth rate of 43.6% per cycle. This was not significantly different. The high AMH group had a live birth rate of 63.9% per cycle, which was significantly different from both the low and the middle AMH groups.

“We do not know why our live birth success rates were so high in the low AMH group. One question this study raises is whether AMH is an accurate and reliable predictor of ovarian reserve. Perhaps AMH levels may not be as predictive of IVF outcome in young women under 35 years of age,” said Dr. Sherbahn.

In conclusion high AMH levels correlate with a low risk for cycle cancellation, retrieval of more eggs, and high live birth rates with in vitro fertilization. However couples should not be excluded from attempting IVF due to low AMH values alone.

Although women with very low AMH levels are sometimes counselled by fertility doctors not to try IVF treatment due to low success chances, our research suggests that low AMH levels do not predict low IVF success rates in women under 35 years old.

The Advanced Fertility Center of Chicago, with offices in Gurnee and Crystal Lake, Ill., offers advanced reproductive technology services such as in-vitro fertilization (IVF), intracytoplasmic sperm injection, preimplantation genetic diagnosis, egg freezing and egg donation.

The Center specializes in individualized care, and has IVF success rates and egg donation success rates that are above the national averages.

The Center’s web site, advancedfertility.com, offers more than 300 articles on fertility issues and IVF. To schedule an appointment, call 847.662.1818.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11249783.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Studies Linking Environmental Toxins to Infertility Validate Benefits of Fairhaven Health's FertileDetox
2. Baby Dreams Come True Through Facebook for Las Vegas Couples Facing Infertility
3. Pregnancy Miracle™ Reveals Holistic Infertility Cure
4. Pregnancy Miracle Review Reveals Effective Infertility Treatment
5. Pregnancy Miracle Review Reveals Lisa Olson's Efficient Infertility Treatment
6. Herbal Medicine Is a New Option for Treating Female Infertility Caused by Tubal Blockage and Hydrosalpinx, Announces Wuhan Dr. Lee’s TCM Clinic
7. Naturally Combat Intake of BPA and Prevent Infertility with Dr. Bob “The Drugless Doctor”
8. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
9. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
10. Reproductive Medicine Associates of New York Now Participating in the WINFertility® Direct-to-Consumer IVF Program
11. Nearly 50 Million Couples Worldwide Report Infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Houston ... Center, is currently offering complimentary consultations and financing for orthodontics for a limited ... bite irregularities and learn about their orthodontic options. Walk-in, late-evening, Saturday, and same-day ...
(Date:1/16/2017)... MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the ... , This year’s influenza shot seems to be having no effect on keeping ... at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... ... , ... San Francisco dentist, Dr. Ben Amini , the founder at ... is capable of taking digital impressions of teeth and gums. Conventional bite impressions have ... restorations , in terms of speed, efficiency and patient comfort. Increasingly, digital impressions are ...
(Date:1/15/2017)... ... 15, 2017 , ... Whole Health Supply, LLC is announcing the release of an updated version ... for purchase. , The 2017 edition has wide jaws that will accommodate nails up ... as well as diabetics. This handle is reinforced for extra strength when pressing down on ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor Rock Climbing Gym is ... wraps up on the 14,000+ square foot climbing gym, the owners anticipate to open ... in New Jersey and two in New York. With this being its first location ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP ... of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... through October 31, 2016 (the "Class Period"). Zimmer ... and markets orthopaedic reconstructive products, such as knee and hip ... ...
(Date:1/13/2017)... Eli Lilly and Company (NYSE: ... ) announced today that the U.S. Food and Drug ... new drug application (NDA) for investigational baricitinib, a once-daily ... rheumatoid arthritis (RA). The NDA for baricitinib was submitted ... FDA extended the action date to allow time to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
Breaking Medicine Technology: